Why an Oncologist Left the Clinic
from TayTalks
Former phase 1 oncologist and neuroendocrine tumor specialist turned biotech leader Nanu Das joins host Taymeyah Al-Toubah to talk pivots, patient impact, and why early-stage trials are becoming the “new phase two.” Why hit play: Hear the moment Nanu knew he had to leave clinic life, despite loving patient care. Steal his framework for choosing mentors (and being the kind of mentee they fight to help). Learn why your first job in pharma shapes your influence on study design. See how targeted imaging could replace repeat biopsies in cancer care. Decide if AI in oncology is hype or a quiet revolution in the making. Send this to the friend debating a big career pivot, then tag @taytalks_pod with your takeaway so we can repost it. ✅ Subscribe on Apple Podcasts, Spotify, or your favorite app—so you never miss a TayTalks deep-dive on nonlinear paths and full-circle moments. 🎙️ Come for the science. Stay for the reminder that you can change the system without losing yourself in it. 🤍 If this episode resonated: Share it with one friend who needs to hear it. Tag @taytalks_pod with your takeaway so we can repost you. Leave a quick rating on Apple or Spotify. Your words help more ambitious humans find the show.
Embed this episode
No transcript yet.